Open access · CC-BY
via OpenAlex
Optimizing preclinical models of ageing for translation to clinical trials
Sarah J. Mitchell, Michael R. MacArthur, Alice E. Kane
British Journal of Clinical Pharmacology · 2023 · ▲ 12 citations
Abstract
Preclinical models have been the backbone of translational research for more than a century. Rats and mice are critical models in the preliminary stages of drug testing, both for determining efficacy and ruling out potential human-relevant toxicities. Historically, most preclinical pharmacological studies have used young, relatively healthy, inbred male models in highly controlled environments. In the field of geriatric pharmacology, there is a growing focus on the importance of using more appropriate preclinical models both in the testing of therapeutics commonly used in older populations, and in the evaluation of potential geroprotective drug candidates. Here we provide a commentary on optimizing preclinical models of ageing for translation to clinical trials. We will discuss approaches to modelling clinically relevant contexts such as age, sex, genetic diversity, exposures and environment, as well as measures of clinically relevant outcomes such as frailty and healthspan(definition). We will identify the strengths and limitations of these approaches and areas for improvement. We will also briefly cover new preclinical models that move beyond rodents. We hope this commentary will be a springboard for larger discussions on optimizing preclinical ageing models for testing therapeutics.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/bcp.15902
- Canonical
- link ↗
- Fetched
- 2026-09-13 MST
Cite this
APA
Mitchell, S.J., MacArthur, M.R., & Kane, A.E. (2023). Optimizing preclinical models of ageing for translation to clinical trials. <em>British Journal of Clinical Pharmacology</em>. https://doi.org/10.1111/bcp.15902
Vancouver
Mitchell SJ, MacArthur MR, Kane AE. Optimizing preclinical models of ageing for translation to clinical trials. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15902.
BibTeX
@article{sarah2023Optimi,
title = {Optimizing preclinical models of ageing for translation to clinical trials},
author = {Sarah J. Mitchell and Michael R. MacArthur and Alice E. Kane},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
doi = {10.1111/bcp.15902},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Kochi University 2019
Open access · US-GOV
Both Short- and Long-term Outcome Differences According to Patient Frailty
Mechanisms of Ageing and Development 2016
Open access · CC-BY
Frailty in mouse ageing: A conceptual approach
Current Opinion in Oncology 2017
Preprint · OA
Elderly patients with multiple myeloma: towards a frailty approach?
Van Training and Research Hospital 2026
Open access · US-GOV
Prognostic Value of the Fried Frailty Index and Clinical Frailty Scale for Postoperative Length of Hospital Stay, Mortality, and Complications in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Prospective Cohort Study
Electronic Journal of General Medicine 2019
Open access · CC-BY
Metformin: A stroke of luck
University of Liege 2023
Open access · US-GOV